ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Longboard Pharmaceuticals, Inc.

Core Viewpoint - Rowley Law PLLC is investigating potential securities law violations by Longboard Pharmaceuticals, Inc. in relation to its proposed acquisition by H. Lundbeck A/S, which is valued at approximately $2.6 billion [1]. Group 1: Acquisition Details - Longboard Pharmaceuticals stockholders will receive $60.00 for each share they hold in the company [1]. - The acquisition transaction is expected to close in the fourth quarter of 2024 [1]. Group 2: Legal Investigation - Rowley Law PLLC is representing shareholders in the investigation concerning the acquisition [1]. - Additional information regarding the investigation can be obtained by contacting Rowley Law PLLC [2].